| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 961 |
| 1 | METHOTREXATE | 893 |
| 2 | CYCLOPHOSPHAMIDE | 887 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 887 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 887 |
| 5 | CYTARABINE | 742 |
| 6 | DEXAMETHASONE | 710 |
| 7 | DEXAMETHASONE 1.5 MG | 710 |
| 8 | PEGASPARGASE | 684 |
| 9 | CARBOPLATIN | 547 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IODINE 2% | 3 | 0.3000 |
| 1 | PEGASPARGASE | 684 | 0.0553 |
| 2 | NALMEFENE HYDROCHLORIDE | 2 | 0.0465 |
| 3 | PURIXAN | 32 | 0.0411 |
| 4 | THIOGUANINE | 70 | 0.0329 |
| 5 | ETOPOSIDE PHOSPHATE | 39 | 0.0239 |
| 6 | DEXCHLORPHENIRAMINE MALEATE | 18 | 0.0179 |
| 7 | NALBUPHINE HYDROCHLORIDE | 4 | 0.0175 |
| 8 | APREPITANT | 118 | 0.0157 |
| 9 | IDECABTAGENE VICLEUCEL | 17 | 0.0137 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1369 |
| 1 | Alkylating Drug [EPC] | 1143 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 1067 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1053 |
| 4 | Platinum-based Drug [EPC] | 784 |
| 5 | Asparagine-specific Enzyme [EPC] | 684 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 506 |
| 7 | Sulfonamide Antimicrobial [EPC] | 493 |
| 8 | Topoisomerase Inhibitor [EPC] | 418 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 374 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 684 | 0.0507 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 118 | 0.0135 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 74 | 0.0126 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 28 | 0.0115 |
| 4 | CD30-directed Immunoconjugate [EPC] | 66 | 0.0063 |
| 5 | Actinomycin [EPC] | 14 | 0.0063 |
| 6 | Topoisomerase Inhibitor [EPC] | 418 | 0.0054 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 506 | 0.0053 |
| 8 | Alkylating Drug [EPC] | 1143 | 0.0047 |
| 9 | CD33-directed Immunoconjugate [EPC] | 17 | 0.0046 |